Finance CRWE-PR

Twitter Inc (TWTR) Tweets Strong Performance on Twitterer Growth, Hansen Medical (HNSN) Robot-Assisted Uterine Artery Embolization Procedures Feasible

Twitter Inc. (TWTR) reported strong financial and operating results, above Wall Street's expectations

Keep a close eye on Twitter, Inc. (TWTR). The company reported strong financial and operating results, above Wall Street's expectations.

For the second quarter 2014, TWTR posted revenue of $312 million, an increase of 124% year over year, and Non-GAAP net income of $14.6 million, or $0.02 per diluted share, compared to a Non-GAAP net loss of $16.4 million, or ($0.12) per diluted share.

As of June 30, 2014, cash, cash equivalents and marketable securities were approximately $2.1 billion, compared to $2.2 billion as of March 31, 2014.

Twitter users surged to 271 million in the second quarter, from 255 million monthly active users in December. Those users sent an average of 500 million Tweets a day.

According to its business outlook for the third quarter of 2014, TWTR expects revenue to be in the range of $330 million to $340 million, while for the full year 2014 TWTR's revenue is projected to be in the range of $1.31 billion to $1.33 billion.

TWTR is a global platform for public self-expression and conversation in real time

More about Twitter, Inc. (TWTR) at,


Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network (, a social networking service which business model is based on selling advertising to businesses targeting both locally and nationally.

The CRWE Network has reached the 1084th community website in the U.S., associated with 2655 ZIP Codes, and includes coverage of the greater state of California, Northern and Southern Nevada, Wellington in Florida, Hattiesburg in Mississippi and 10 provinces in Canada.

CRWE Network's goal is to facilitate exchanges of goods and services in a manner similar to Craigslist, a classified advertisements website with sections devoted to jobs, housing, personals, for sale, items wanted, services, community, gigs, resumes, and discussion forums, while providing micro community news, information and business directory content.

The CRWE-PR Finance website ( ) allows Crown Equity Holdings the instant distribution of information to the entire CRWE Network.

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at


Uterine fibroids are tumors that grow in a woman's womb. They are the most common benign tumors in women and the leading cause for hysterectomies in the US. As many as 1 in 5 women may have fibroids during their childbearing years. Half of all women have fibroids by age 50.

Uterine artery embolization is a minimally-invasive treatment option for uterine fibroids in which a catheter is used to deliver small particles into the uterine artery to stop blood flow to the fibroids.

Hansen Medical, Inc. 's (HNSN) Magellan Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. HNSN's Magellan Robotic System is designed to deliver improved predictability, control and catheter stability to endovascular procedures.

HNSN reported that a study, published online in the Journal of Vascular Interventional Radiology, found the use of the HNSN's Magellan Robotic System in uterine artery embolization ("UAE") procedures is feasible and appears to be safe.

Researchers reviewed the results of five patients treated with robot-assisted UAE over a 10 month period. They conducted the study to investigate the safety and feasibility of the Magellan 9Fr Robotic Catheter in this complex arterial bed.

All procedures were successfully completed without local puncture site complications or access vessel injuries. Further, robotic bilateral internal iliac artery cannulation was successfully performed in all cases. At the six-month follow-up mark, all patients reported significant improvement in symptoms and quality-of-life.

HNSN is a global leader in Intravascular Robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies.

More about Hansen Medical, Inc. (HNSN) at


CRWE-PR Finance

Read Full Disclaimer at

Categories: Stocks

Tags: CRWE Network, CRWE-PR Finance, Hansen Medical, HNSN, Nasdaq:HNSN, NYSE:TWTR, Twitter Inc, TWTR, uterine artery embolization, Uterine fibroids

About Finance CRWE-PR

View Website

Finance CRWE-PR
11226 Pentland Downs Street
Las Vegas, NV 89141